Just reported
From SkinHealth Systems's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$69.2M
-2.1% y/y
-4.1% q/q
Guided
$67.5M
midpoint
Actual
-$0.14
Guided
—
No guide given
Actual
$5M
+39% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes SkinHealth Systems is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from SkinHealth Systems Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
SKIN · Nasdaq · Consumer Staples · Household and Personal Products
$16.46+2.9%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Company outlook: revenue of $281M to $287M for Fiscal year 2026 — down 5.6% on a year earlier ($300.8M)
Grade F-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 20 quarters of SkinHealth Systems Inc.’s grade history. The other 18 go back to March 2022.